News
Researchers recently discovered that an experimental cancer vaccine offers "a promising approach" to preventing cancers from ...
Zev A. Wainberg, MD, discussed the significance of the AMPLIFY-201 trial, next steps for this vaccine platform, and the signs ...
Researchers found that the vaccine, named ELI-002 2P, could trigger lasting immune responses and may help prevent or delay ...
The firm will use the funding to support a Phase I/II umbrella trial of three TCR T-cell candidates and its preclinical pipeline.
In a phase 1 study, ELI-002 2P improved relapse-free survival in pancreatic and colorectal cancer, with stronger benefit in ...
The second round of the Eredivisie brought FC Utrecht their first loss and saw AZ drop valuable points away at FC Volendam.
For three colorectal cancer patients and three pancreatic cancer patients, the vaccine appeared to remove all disease ...
Phase 1 trial of a pancreatic cancer vaccine targeting mutant KRAS shows strong immune responses, extended survival, and ...
A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...
Eredivisie history was written in Velsen-Zuid when PEC Zwolle midfielder Jadiel Pereira da Gama made his debut and thus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results